Genentech Adds Lupus Nephritis To Cancer Indications On Gazyva’s Label

 
• By Joseph Haas
  
Genetech
Genentech gets new indication for Gavyza, active lupus nephritis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business